Molecular Scaffolds Direct MAPK Signaling Specificity

分子支架直接 MAPK 信号转导特异性

基本信息

  • 批准号:
    7236130
  • 负责人:
  • 金额:
    $ 23.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-07-01 至 2009-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Normal cellular function is dependent on the ability of environmental signals to elicit distinct responses through activation of specific cell surface receptors, and yet these signals often converge on the same members of the MAPK family. How can cells maintain specificity of signal transduction when so many different receptors ultimately activate the same enzyme? My previous work helped establish that components of the endocytotic machinery, (e.g. b-arrestin), can assemble scaffolding complexes that direct the subcellular localization, duration and outcome of MAPK activity. These studies investigate the mechanism by which these endosomal scaffolds can direct distinct cellular outcomes, by characterizing a molecular scaffold formed in response to protease-activated receptor-2 (PAR-2) that promotes chemotaxis by sequestering and prolonging MAPK activity at the leading edge and comparing it to one formed in response to a receptor that promotes nuclear translocation of MAPK and proliferation. We pose the following questions: 1) Does the PAR-2 endosomal scaffold sequester MAPK to a subcellular domain where it directs localized reorganization of the cytoskeleton? 2) Do receptor/b-arrestin interactions and molecular contacts within each endosomal scaffold and ultimately determine the outcome of receptor activation? 3) How does the endosomal scaffold control kinase activity in a specialized region of the cell? Understanding the mechanism by which endosomal scaffolds determine signaling specificity is important from a fundamental cell biological perspective as recent studies suggest this mechanism is utilized by a wide variety of receptors. Furthermore, the receptor on which this study focuses, PAR-2, is involved in a plethora of normal physiological and pathological processes; two areas studied in our laboratory are tumor metastasis and maintenance of colonic epithelial integrity. Therefore, understanding the molecular basis of PAR-2 signaling may ultimately lead to new targets for the treatment of metastasis and inflammatory bowel diseases.
描述(由申请人提供):正常细胞功能依赖于环境信号通过激活特定细胞表面受体引发不同反应的能力,但这些信号通常集中在MAPK家族的相同成员上。当这么多不同的受体最终激活同一种酶时,细胞如何保持信号转导的特异性?我之前的工作帮助确定了内吞机制的组成部分(例如b-抑制蛋白)可以组装支架复合物,指导MAPK活性的亚细胞定位、持续时间和结果。这些研究通过表征响应于蛋白酶激活受体-2(PAR-2)形成的分子支架(其通过在前沿隔离和延长MAPK活性来促进趋化性)并将其与响应于促进MAPK核转位和增殖的受体形成的分子支架进行比较,来研究这些内体支架可以指导不同细胞结果的机制。我们提出以下问题:1)PAR-2内体支架是否将MAPK隔离到亚细胞结构域,在那里它指导细胞骨架的局部重组?2)受体/b-抑制蛋白相互作用和分子接触是否决定了受体激活的结果?3)内体支架如何控制细胞特定区域的激酶活性?从基本细胞生物学的角度来看,了解内体支架决定信号传导特异性的机制是重要的,因为最近的研究表明这种机制被各种各样的受体利用。此外,本研究关注的受体PAR-2参与了过多的正常生理和病理过程;我们实验室研究的两个领域是肿瘤转移和结肠上皮完整性的维持。因此,了解PAR-2信号传导的分子基础可能最终导致治疗转移和炎症性肠病的新靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kathryn Anne DeFea其他文献

Kathryn Anne DeFea的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kathryn Anne DeFea', 18)}}的其他基金

Molecular Scaffolds Direct MAPK Signaling Specificity
分子支架直接 MAPK 信号转导特异性
  • 批准号:
    7921247
  • 财政年份:
    2009
  • 资助金额:
    $ 23.64万
  • 项目类别:
Role of beta-arrestin-dependent chemotaxis in protease-activated-receptor-2-induc
β-抑制蛋白依赖性趋化作用在蛋白酶激活受体 2 诱导中的作用
  • 批准号:
    7596895
  • 财政年份:
    2008
  • 资助金额:
    $ 23.64万
  • 项目类别:
Role of beta-arrestin-dependent chemotaxis in protease-activated-receptor-2-induc
β-抑制蛋白依赖性趋化作用在蛋白酶激活受体 2 诱导中的作用
  • 批准号:
    7451410
  • 财政年份:
    2008
  • 资助金额:
    $ 23.64万
  • 项目类别:
Molecular Scaffolds Direct MAPK Signaling Specificity
分子支架直接 MAPK 信号转导特异性
  • 批准号:
    7087041
  • 财政年份:
    2004
  • 资助金额:
    $ 23.64万
  • 项目类别:
Molecular Scaffolds Direct MAPK Signaling Specificity
分子支架直接 MAPK 信号转导特异性
  • 批准号:
    6824500
  • 财政年份:
    2004
  • 资助金额:
    $ 23.64万
  • 项目类别:
Molecular Scaffolds Direct MAPK Signaling Specificity
分子支架直接 MAPK 信号转导特异性
  • 批准号:
    7458623
  • 财政年份:
    2004
  • 资助金额:
    $ 23.64万
  • 项目类别:
Molecular Scaffolds Direct MAPK Signaling Specificity
分子支架直接 MAPK 信号转导特异性
  • 批准号:
    6916546
  • 财政年份:
    2004
  • 资助金额:
    $ 23.64万
  • 项目类别:
CELLULAR MECHANISM FOR INSULIN RESISTANCE
胰岛素抵抗的细胞机制
  • 批准号:
    2136391
  • 财政年份:
    1996
  • 资助金额:
    $ 23.64万
  • 项目类别:
CELLULAR MECHANISM FOR INSULIN RESISTANCE
胰岛素抵抗的细胞机制
  • 批准号:
    2136390
  • 财政年份:
    1996
  • 资助金额:
    $ 23.64万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了